Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products.
作者信息
Mori Filippo, Salvatore Alfonso, Ascione Ester, Di Marzo Raffaele, Fox Bernard
机构信息
Department of Research and Innovation, Kedrion S.p.A., Lucca, Italy.
Department of Industrial Development, Kedrion S.p.A., Naples, Italy.
出版信息
Vox Sang. 2022 Apr;117(4):624-625. doi: 10.1111/vox.13213. Epub 2021 Oct 26.
Abstract
摘要
相似文献
1
Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products.预防性多克隆抗-D抗体的评估：商业产品中Fc糖基化的差异。
Vox Sang. 2022 Apr;117(4):624-625. doi: 10.1111/vox.13213. Epub 2021 Oct 26.
2
Functional assessment of therapeutic anti-D immunoglobulin using Fc-mediated assays.
Transfus Med. 1995 Mar;5(1):21-9. doi: 10.1111/j.1365-3148.1995.tb00181.x.
3
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc -Glycosylation.基于 MS 的多克隆 IgG-Fc-糖基化的同种型特异性分析。
Front Immunol. 2020 Aug 21;11:2049. doi: 10.3389/fimmu.2020.02049. eCollection 2020.
4
Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.使用一种新的质谱高通量分析方法对免疫球蛋白G（IgG）Fab糖基化进行分析，揭示了与妊娠相关的变化。
Mol Cell Proteomics. 2014 Nov;13(11):3029-39. doi: 10.1074/mcp.M114.039537. Epub 2014 Jul 8.
5
Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.内脏利什曼病的临床严重程度与免疫球蛋白G Fc N-糖基化的变化有关。
mBio. 2014 Dec 2;5(6):e01844. doi: 10.1128/mBio.01844-14.
6
A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis.一种通过毛细管电泳对IgG Fc和Fab糖基化进行高通量、灵敏分析的方法。
J Immunol Methods. 2015 Feb;417:34-44. doi: 10.1016/j.jim.2014.12.004. Epub 2014 Dec 15.
7
Effector properties and glycosylation patterns of recombinant human anti-D-IgG1 antibodies produced by human PER.C6(®) cells.人源PER.C6(®)细胞产生的重组人抗-D-IgG1抗体的效应子特性和糖基化模式
Bull Exp Biol Med. 2012 Dec;154(2):245-9. doi: 10.1007/s10517-012-1923-1.
8
Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis.IgG Fc 糖基化的差异与儿童脑膜炎球菌性败血症的结局相关。
mBio. 2018 Jun 19;9(3):e00546-18. doi: 10.1128/mBio.00546-18.
9
Immunoglobulin G Fc N-glycosylation in Guillain-Barré syndrome treated with intravenous immunoglobulin.静脉注射免疫球蛋白治疗的吉兰-巴雷综合征中免疫球蛋白G Fc N-糖基化
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):105-7. doi: 10.1111/cei.12530.
10
IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia.免疫性血小板减少症患者利妥昔单抗治疗前后 IgG-Fc 糖基化。
Sci Rep. 2020 Feb 20;10(1):3051. doi: 10.1038/s41598-020-59651-7.
本文引用的文献
1
Four keys to unlock IgG.解锁 IgG 的四把钥匙。
J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20201753.
2
FIGO/ICM guidelines for preventing Rhesus disease: A call to action.FIGO/ICM 指南：预防 Rh 同种免疫疾病——行动呼吁。
Int J Gynaecol Obstet. 2021 Feb;152(2):144-147. doi: 10.1002/ijgo.13459. Epub 2021 Jan 9.
3
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.来自 23 个人源和啮齿动物细胞系的抗-D 单克隆抗体表现出不同的 IgG Fc-糖基化谱，决定了它们的临床疗效。
Sci Rep. 2020 Jan 30;10(1):1464. doi: 10.1038/s41598-019-57393-9.
4
Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.预防性抗-D制剂显示抗-D的Fc-岩藻糖基化有不同程度的降低。
Transfusion. 2015 Mar;55(3):553-62. doi: 10.1111/trf.12880. Epub 2014 Sep 19.
5
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.RhD单克隆抗体在临床试验中作为预防性抗-D免疫球蛋白替代疗法的疗效：问题多于答案。
Vox Sang. 2007 Aug;93(2):99-111. doi: 10.1111/j.1423-0410.2007.00945.x.
Zotero 插件